Breaking News Instant updates and real-time market news.

HEXO

Hexo

$2.07

-0.11 (-5.05%)

06:58
11/05/19
11/05
06:58
11/05/19
06:58

Hexo initiated with an Underweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Pablo Zuanic initiated coverage of Hexo with an Underweight rating and C$2.40 price target. The company has "big ambitions," and some of its previously stated targets may have helped the stock, but its performance so far and announced plans to date "are not aligned with the vision," Zuanic tells investors in a research note.

  • 12

    Nov

  • 12

    Nov

HEXO Hexo
$2.07

-0.11 (-5.05%)

10/25/19
CIBC
10/25/19
DOWNGRADE
CIBC
Underperformer
Hexo downgraded to Underperformer from Neutral at CIBC
CIBC analyst John Zamparo downgraded Hexo to Underperformer from Neutral with a price target of C$3, down from C$4. The analyst said Hexo's announcement of 200 job cuts is a "worrisome" sign and indicates the situation is more challenging than previously contemplated. Zamparo thinks Hexo has not been able to capture meaningful share outside its home province, and does not believe investor's will wait for Quebec's lack of retail footprint to be addressed. Further, the analyst questions the timing of the structured convertible debt saying it adds another question mark.
10/29/19
ROTH
10/29/19
NO CHANGE
Target $2.5
ROTH
Neutral
Hexo price target cut to $2.50 from $3 at Roth Capital
Roth Capital analyst Scott Fortune cut his price target on Hexo to $2.50 from $3 after the company reported Q4 results and provided a "soft" guidance for Q1. Fortune, who also lowered his 2020 estimates for Hexo, noted that management cited lower than expected sell-through due to slower than anticipated retail store openings, "weak" specific product sales, and competitive pricing pressures. The analyst, who kept a Neutral rating on the stock, said he expects Canadian short-term negative pressure to remain and doesn't expect positive earnings per share or adjusted EBITDA until the end of 2020.
10/30/19
ADAM
10/30/19
DOWNGRADE
ADAM
Hold
Hexo downgraded to Hold from Speculative Buy at Canaccord
Canaccord Genuity analyst Matt Bottomley downgraded Hexo to Hold from Speculative Buy with a price target of C$3.50.
10/30/19
EGCP
10/30/19
DOWNGRADE
EGCP
Sell
Hexo downgraded to Sell from Neutral at Eight Capital
Eight Capital analyst Graeme Kreindler downgraded Hexo to Sell from Neutral.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$286.74

-2.61 (-0.90%)

11:49
12/05/19
12/05
11:49
12/05/19
11:49
Hot Stocks
Biogen reverses, moves up as CTAD presentation ends, panel Q&A session begins »

Shares of Biogen have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

AUPH

Aurinia Pharmaceuticals

$15.83

7.45 (88.90%)

11:49
12/05/19
12/05
11:49
12/05/19
11:49
Recommendations
Aurinia Pharmaceuticals analyst commentary  »

Aurinia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

KMI

Kinder Morgan

$19.45

0.15 (0.78%)

11:45
12/05/19
12/05
11:45
12/05/19
11:45
Options
Kinder Morgan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNSS

Sunesis

$0.24

-0.1499 (-38.45%)

11:44
12/05/19
12/05
11:44
12/05/19
11:44
Hot Stocks
Sunesis announces data from ongoing Phase 1b/2 trial of vecabrutinib »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

BIIB

Biogen

$286.74

-2.61 (-0.90%)

11:39
12/05/19
12/05
11:39
12/05/19
11:39
Hot Stocks
Biogen down 3% as trading resumes, medical conference presentation continues »

Biogen representatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

SAGE

Sage Therapeutics

$63.85

-85.37 (-57.21%)

11:38
12/05/19
12/05
11:38
12/05/19
11:38
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VST

Vistra Energy

$24.45

-0.66 (-2.63%)

11:35
12/05/19
12/05
11:35
12/05/19
11:35
Options
Vistra Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
12/05/19
12/05
11:35
12/05/19
11:35
General news
Today's U.S. reports »

Today's U.S. reports…

BIIB

Biogen

$286.74

-2.61 (-0.90%)

11:35
12/05/19
12/05
11:35
12/05/19
11:35
Hot Stocks
Breaking Hot Stocks news story on Biogen 

Biogen trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

11:30
12/05/19
12/05
11:30
12/05/19
11:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

ACAD

Acadia

$51.31

7.09 (16.03%)

11:25
12/05/19
12/05
11:25
12/05/19
11:25
Recommendations
Acadia analyst commentary  »

Acadia's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBT

Global Blood Therapeutics

$75.73

1.43 (1.92%)

11:25
12/05/19
12/05
11:25
12/05/19
11:25
Options
Global Blood Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 26

    Feb

SRC

Spirit Realty

$52.25

-0.82 (-1.55%)

11:25
12/05/19
12/05
11:25
12/05/19
11:25
Conference/Events
Spirit Realty to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

QUIK

QuickLogic

$0.25

(0.00%)

11:22
12/05/19
12/05
11:22
12/05/19
11:22
Hot Stocks
QuickLogic announces death of Chairman E. Thomas Hart »

QuickLogic earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SPXC

SPX Corporation

$48.37

0.245 (0.51%)

11:19
12/05/19
12/05
11:19
12/05/19
11:19
Conference/Events
SPX Corporation management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SAGE

Sage Therapeutics

$65.72

-83.5 (-55.96%)

11:19
12/05/19
12/05
11:19
12/05/19
11:19
Recommendations
Sage Therapeutics analyst commentary  »

Stifel cuts Sage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$63.45

0.24 (0.38%)

11:17
12/05/19
12/05
11:17
12/05/19
11:17
Conference/Events
Sensient management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

BIIB

Biogen

$286.74

-2.61 (-0.90%)

11:17
12/05/19
12/05
11:17
12/05/19
11:17
Hot Stocks
Biogen finalizing details of a re-dosing study for aducanumab »

In slides for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/05/19
12/05
11:17
12/05/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAVN

Raven

$34.96

-0.01 (-0.03%)

11:16
12/05/19
12/05
11:16
12/05/19
11:16
Conference/Events
Raven management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/05/19
12/05
11:16
12/05/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEI

American Public Education

$24.77

-0.32 (-1.28%)

11:15
12/05/19
12/05
11:15
12/05/19
11:15
Conference/Events
American Public Education management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Treasury announced $78 B in 3-, 10-, and 30-year maturities »

Treasury announced $78 B…

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.